Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.

Swati SakhujaVera A BittnerTodd M BrownMichael E FarkouhEmily B LevitanMonika M SaffordMark WoodwardLigong ChenRuoyan SunNafeesa DhalwaniJenna JonesBethany KalichJason ExterPaul MuntnerRobert S RosensonLisandro D Colantonio

Published in: Cardiovascular drugs and therapy (2023)

Implementation of guideline-recommended cholesterol-lowering therapy could prevent a substantial percentage of recurrent ASCVD events.

Keyphrases

cardiovascular disease
healthcare
primary care
low density lipoprotein
heart failure
type diabetes
left ventricular
metabolic syndrome
stem cells
bone marrow
mesenchymal stem cells
cardiovascular risk factors